The ability to eliminate specific pathologic cells is creating more options for multiple myeloma patients ... senior director of translational research at Bristol-Myers Squibb (BMS).

The study, published in Pharmacological Research, offers a potential new strategy to improve outcomes for patients whose disease has become less responsive to standard therapies. Multiple myeloma ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in ...

The study, published in Pharmacological Research, offers a potential new strategy to improve outcomes for patients whose disease has become less responsive to standard therapies. Multiple myeloma ...

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone ... The standard therapy for people with myeloma is high-dose chemotherapy together with a ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in ...

Researchers in Birmingham have secured £230,000 in translational funding from Cancer Research Horizons to ... individuals at risk of developing multiple myeloma, a form of blood cancer (1 ...

When you have treatment for multiple myeloma, the hope is the medicines ... This is known as precision medicine, and it’s the newest treatment option. Made in a lab, these drugs can attach ...

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets ...